Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.

Mayerhoefer ME, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C, Berzaczy D, Raderer M, Preusser M, Hochmair M, Kiesewetter B, Scheuba C, Ba-Ssalamah A, Karanikas G, Kesselbacher J, Prager G, Dieckmann K, Polterauer S, Weber M, Rausch I, Brauner B, Eidherr H, Wadsak W, Haug AR.

Eur J Nucl Med Mol Imaging. 2019 Aug 13. doi: 10.1007/s00259-019-04452-y. [Epub ahead of print]

PMID:
31410538
2.

Whole-Body [18F]FDG-PET/MRI vs. [18F]FDG-PET/CT in Malignant Melanoma.

Berzaczy D, Fueger B, Hoeller C, Haug AR, Staudenherz A, Berzaczy G, Weber M, Mayerhoefer ME.

Mol Imaging Biol. 2019 Jul 30. doi: 10.1007/s11307-019-01413-7. [Epub ahead of print]

PMID:
31363965
3.

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.

Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, Shustov A, Tournilhac O, Bachy E, Zaja F, Porkka K, Hoermann G, Simonitsch-Klupp I, Haferlach C, Kubicek S, Mayerhoefer ME, Hopfinger G, Jaeger U, Dearden C.

Blood. 2019 Oct 3;134(14):1132-1143. doi: 10.1182/blood.2019000402. Epub 2019 Jul 10. Review.

PMID:
31292114
4.

Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma.

Mayerhoefer ME, Riedl CC, Kumar A, Gibbs P, Weber M, Tal I, Schilksy J, Schöder H.

Eur J Nucl Med Mol Imaging. 2019 Jul 8. doi: 10.1007/s00259-019-04420-6. [Epub ahead of print]

PMID:
31286200
5.

Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.

Kiesewetter B, Lamm W, Neuper O, Mayerhoefer ME, Simonitsch-Klupp I, Raderer M.

Hematol Oncol. 2019 Jul 8. doi: 10.1002/hon.2647. [Epub ahead of print]

PMID:
31283840
6.

Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga]Ga-Pentixafor-PET/MRI.

Haug AR, Leisser A, Wadsak W, Mitterhauser M, Pfaff S, Kropf S, Wester HJ, Hacker M, Hartenbach M, Kiesewetter-Wiederkehr B, Raderer M, Mayerhoefer ME.

Theranostics. 2019 May 27;9(12):3653-3658. doi: 10.7150/thno.31032. eCollection 2019.

7.

MRI and PET/MRI in hematologic malignancies.

Mayerhoefer ME, Archibald SJ, Messiou C, Staudenherz A, Berzaczy D, Schöder H.

J Magn Reson Imaging. 2019 Jul 1. doi: 10.1002/jmri.26848. [Epub ahead of print] Review.

PMID:
31260155
8.

Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.

Kiesewetter B, Lamm W, Dolak W, Lukas J, Mayerhoefer ME, Weber M, Schiefer AI, Kornauth C, Bayer G, Simonitsch-Klupp I, Raderer M.

Br J Haematol. 2019 Aug;186(3):448-459. doi: 10.1111/bjh.15953. Epub 2019 May 24.

9.

Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non-Small Cell Lung Cancer.

Beer L, Hochmair M, Haug AR, Schwabel B, Kifjak D, Wadsak W, Fuereder T, Fabikan H, Fazekas A, Schwab S, Mayerhoefer ME, Herold C, Prosch H.

Clin Nucl Med. 2019 Jul;44(7):535-543. doi: 10.1097/RLU.0000000000002603.

PMID:
31021918
10.

Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study.

Berzaczy D, Haug AR, Raderer M, Kiesewetter B, Berzaczy G, Weber M, Mayerhoefer ME.

PLoS One. 2019 Mar 8;14(3):e0213551. doi: 10.1371/journal.pone.0213551. eCollection 2019.

11.

Pre-Therapeutic Total Lesion Glycolysis on [18F]FDG-PET Enables Prognostication of 2-Year Progression-Free Survival in MALT Lymphoma Patients Treated with CD20-Antibody-Based Immunotherapy.

Mayerhoefer ME, Staudenherz A, Kiesewetter B, Weber M, Simonitsch-Klupp I, Gibbs P, Dolak W, Lukas J, Raderer M.

Mol Imaging Biol. 2019 Mar 7. doi: 10.1007/s11307-019-01329-2. [Epub ahead of print]

PMID:
30847823
12.

Heavy black tea consumption and elevated CA 19-9 and CA 125 levels. A case report on a patient with ovarian endometriotic cysts.

Pils S, Paternostro C, Mayerhoefer ME, Reinthaller A, Feichtinger M.

Gynecol Endocrinol. 2019 Jun;35(6):478-480. doi: 10.1080/09513590.2018.1564743. Epub 2019 Feb 6.

PMID:
30727790
13.

Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trial.

Lagler H, Kiesewetter B, Dolak W, Obermueller M, Simonitsch-Klupp I, Lukas J, Neuper O, Lamm WW, Mayerhoefer ME, Raderer M.

Hematol Oncol. 2019 Feb;37(1):22-26. doi: 10.1002/hon.2555. Epub 2018 Sep 19.

14.

DWI-MRI vs CT in gastric MALT lymphoma-preliminary results in 19 patients.

Berzaczy D, Staudenherz A, Raderer M, Weber M, Mayerhoefer ME.

Br J Radiol. 2018 Jul 24:20180263. doi: 10.1259/bjr.20180263. [Epub ahead of print]

PMID:
30040435
15.

Successful Clarithromycin Monotherapy in a Patient with Primary Follicular Lymphoma of the Duodenum.

Kiesewetter B, Dolak W, Mayerhoefer ME, Simonitsch-Klupp I, Raderer M.

Case Rep Oncol. 2018 Apr 11;11(1):239-245. doi: 10.1159/000488388. eCollection 2018 Jan-Apr.

16.

[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.

Rasul S, Hartenbach S, Rebhan K, Göllner A, Karanikas G, Mayerhoefer M, Mazal P, Hacker M, Hartenbach M.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2159-2169. doi: 10.1007/s00259-018-4045-9. Epub 2018 May 15.

17.

[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.

Mayerhoefer ME, Jaeger U, Staber P, Raderer M, Wadsak W, Pfaff S, Kornauth C, Senn D, Weber M, Wester HJ, Skrabs C, Haug A.

Invest Radiol. 2018 Jul;53(7):403-408. doi: 10.1097/RLI.0000000000000469.

PMID:
29642081
18.

Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment.

Mayerhoefer ME, Raderer M, Jaeger U, Staber P, Kiesewetter B, Senn D, Gallagher FA, Brindle K, Porpaczy E, Weber M, Berzaczy D, Simonitsch-Klupp I, Sillaber C, Skrabs C, Haug A.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):931-940. doi: 10.1007/s00259-018-3937-z. Epub 2018 Feb 26.

19.

Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?

Berzaczy D, Mayerhoefer ME, Azizi AA, Haug AR, Senn D, Beitzke D, Weber M, Traub-Weidinger T.

PLoS One. 2017 Dec 5;12(12):e0189093. doi: 10.1371/journal.pone.0189093. eCollection 2017.

20.

Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.

Asenbaum U, Nolz R, Karanikas G, Furtner J, Woitek R, Simonitsch-Klupp I, Raderer M, Mayerhoefer ME.

Acad Radiol. 2018 Apr;25(4):453-460. doi: 10.1016/j.acra.2017.10.024. Epub 2017 Dec 1.

PMID:
29199055

Supplemental Content

Loading ...
Support Center